Atlas Trials

Arginase Inhibition and Microvascular Endothelial Function in Type 2 Diabetes

Clinical trial NCT02687152 · COMPLETED

Trial details

NCT number
NCT02687152
Sponsor
Karolinska Institutet
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2014-03-01
Primary completion
2015-11-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.